[A new view of psoriasis].
Jullien
D
D
Service de Dermatologie, Hôpital Edouard Herriot, Place d'Arsonval, 69437 Lyon cedex 03, France.
Solignac
M
M
D050197:Atherosclerosis / Q000453:epidemiology; D015331:Cohort Studies; D015897:Comorbidity; D016207:Cytokines / Q000502:physiology; D003713:Dendritic Cells / Q000473:pathology; D005260:Female; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007238:Infarction / Q000453:epidemiology; D007249:Inflammation; D008223:Lymphoma / Q000453:epidemiology; D008297:Male; D024821:Metabolic Syndrome / Q000453:epidemiology; D008954:Models, Biological; D009389:Neovascularization, Pathologic / Q000209:etiology; D011565:Psoriasis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000276:immunology / Q000503:physiopathology* / Q000523:psychology; D016176:T-Lymphocyte Subsets / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology
D016207:Cytokines; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha